?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
Biosimilars Forum
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 30, 2019
Biosimilars Forum
Forum Statement in Response to Senate Finance Committee Advancing its Drug Pricing Package
News
July 25, 2019
Biosimilars Forum
Forum Statement on Senate Finance Provision and New Amendment That Could Save Taxpayers and Seniors Billions
News
July 23, 2019
Biosimilars Forum
Senate Finance Provision Increasing ASP for Biosimilars Could Unlock Billions in Savings for Patients and Taxpayers
News
July 11, 2019
Biosimilars Forum
New Analysis Confirms Increased Use of Biosimilars Can Save U.S. Up to $71 Billion Over a Decade
News
June 20, 2019
Biosimilars Forum
Health Experts Agree Increasing Biosimilar Use Can Help Reduce Rising Drug Costs for Patients
News
May 29, 2019
Biosimilars Forum
Biosimilars Forum Announces Support for Policies that Would Save Taxpayers and Seniors Billions
News
May 23, 2019
Biosimilars Forum
The Biosimilars Forum Commends Senate HELP Committee’s Effort to Educate Patients and Providers on Biosimilars
News
March 19, 2019
Biosimilars Forum
Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market
News
March 7, 2019
Biosimilars Forum
The Biosimilars Forum Disagrees with the Food and Drug Administration’s Decision on Naming of Biologic Medicines
News
March 6, 2019
Biosimilars Forum
The Biosimilars Forum Recognizes Commissioner Gottlieb’s Leadership Supporting a Strong Biosimilars Market in the U.S.
Prev page
01
02
03
04
Next page